CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Jones Mitchell Lawrence See Remarks | Option exercise | +2,620,850 | 2,714,859 | ||
| 2026-10-06 | Jones Mitchell Lawrence See Remarks | Shares withheld for taxes | −1,031,102 | $1.49 | $1.5M | 1,683,757 |
| 2026-10-06 | Jones Mitchell Lawrence See Remarks | Option exercise · Restricted Stock Units | −2,555,266 | 5,110,534 | ||
| 2026-10-06 | Jones Mitchell Lawrence See Remarks | Option exercise · Restricted Stock Units | −65,584 | 590,249 | ||
| 2026-07-07 | Jones Mitchell Lawrence Chief Medical Officer | Sale | −51,880 | $2.05 | $107K | 94,009 |
| 2026-07-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +131,167 | 145,889 | ||
| 2026-07-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −131,167 | 655,833 | ||
| 2026-02-12 | Jones Mitchell Lawrence Chief Medical Officer | Sale | −1,989 | $1.75 | $3K | 13,263 |
| 2026-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +8,000 | 15,252 | ||
| 2026-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −8,000 | 16,000 | ||
| 2026-02-09 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Restricted Stock Units | +787,000 | 787,000 | ||
| 2025-10-06 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Restricted Stock Units | +7,665,800 | 7,665,800 | ||
| 2025-09-04 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Phantom Units | +289,000 | 289,000 | ||
| 2025-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +29,000 | 29,000 | ||
| 2025-02-11 | Jones Mitchell Lawrence Chief Medical Officer | Grant or award · Restricted Stock Units | +24,000 | 24,000 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +2,735 | 3,568 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Shares withheld for taxes | −810 | $4.76 | $4K | 2,758 |
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +1,555 | 4,313 | ||
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Shares withheld for taxes | −461 | $4.76 | $2K | 3,852 |
| 2024-05-28 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −2,735 | 0 |
Page 1 of 2 · 37 trades